RVX.TO
Resverlogix Corp
Price:  
0.05 
CAD
Volume:  
1,008.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVX.TO Relative Valuation

-149.3%
Upside

As of 2025-05-24, the Relative Valuation of Resverlogix Corp (RVX.TO) is (0.02) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.05 CAD, the upside of Resverlogix Corp based on Relative Valuation is -149.3%.

The range of the Relative Valuation is (0.02) - (0.03) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 0.5x - 0.7x 0.6x
Forward P/E multiples - -
Fair Price (0.02) - (0.03) (0.02)
Upside -139.5% - -159.2% -149.3%
0.05 CAD
Stock Price
(0.02) CAD
Fair Price

RVX.TO Relative Valuation - Historical P/E Data

Date P/E
2025-05-22 -1.08
2025-05-21 -1.08
2025-05-16 -1.08
2025-05-14 -1.08
2025-05-12 -1.22
2025-05-07 -1.22
2025-05-06 -1.22
2025-05-05 -1.22
2025-05-02 -0.95
2025-05-01 -1.08
2025-04-30 -1.22
2025-04-29 -1.08
2025-04-25 -1.08
2025-04-24 -1.08
2025-04-23 -1.08
2025-04-22 -0.95
2025-04-21 -1.08
2025-04-17 -1.08
2025-04-16 -1.22
2025-04-15 -1.08
2025-04-11 -1.08
2025-04-10 -1.08
2025-04-09 -1.22
2025-04-08 -1.22
2025-04-07 -1.22
2025-04-04 -1.22
2025-04-03 -1.08
2025-04-02 -1.22
2025-04-01 -1.22
2025-03-31 -1.08
2025-03-28 -1.22
2025-03-27 -1.08
2025-03-25 -1.35
2025-03-24 -1.08
2025-03-21 -1.35
2025-03-20 -1.35
2025-03-19 -1.22
2025-03-17 -1.35
2025-03-14 -1.35
2025-03-12 -1.22
2025-03-11 -1.35
2025-03-10 -1.22
2025-03-06 -1.22
2025-03-04 -1.08
2025-03-03 -1.08
2025-02-28 -1.22
2025-02-27 -1.22
2025-02-26 -1.22
2025-02-25 -1.08
2025-02-24 -1.22